ICAM1 and thyroid gland carcinoma: As a new treatment modality for advanced thyroid cancers, we demonstrated a single infusion of CAR T cells specific to ICAM-1 to be highly efficient in eliminating thyroid tumors in preclinical models, providing long lasting survival benefit5.